These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28547791)

  • 1. An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin.
    Meier SM; Kreutz D; Winter L; Klose MHM; Cseh K; Weiss T; Bileck A; Alte B; Mader JC; Jana S; Chatterjee A; Bhattacharyya A; Hejl M; Jakupec MA; Heffeter P; Berger W; Hartinger CG; Keppler BK; Wiche G; Gerner C
    Angew Chem Int Ed Engl; 2017 Jul; 56(28):8267-8271. PubMed ID: 28547791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-dependent shotgun proteomics revealed distinct effects of an organoruthenium prodrug and its activation product on colon carcinoma cells.
    Meier-Menches SM; Zappe K; Bileck A; Kreutz D; Tahir A; Cichna-Markl M; Gerner C
    Metallomics; 2019 Jan; 11(1):118-127. PubMed ID: 30106070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plecstatin-1 induces an immunogenic cell death signature in colorectal tumour spheroids.
    Wernitznig D; Meier-Menches SM; Cseh K; Theiner S; Wenisch D; Schweikert A; Jakupec MA; Koellensperger G; Wernitznig A; Sommergruber W; Keppler BK
    Metallomics; 2020 Dec; 12(12):2121-2133. PubMed ID: 33295928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Metal Center and Leaving Group on the Anticancer Activity of Organometallic Complexes of Pyridine-2-carbothioamide.
    Arshad J; Tong KKH; Movassaghi S; Söhnel T; Jamieson SMF; Hanif M; Hartinger CG
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33562622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antitumor studies of organoruthenium complexes with 8-hydroxyquinolines on 2D and 3D cell models of bone, lung and breast cancer.
    Ruiz MC; Kljun J; Turel I; Di Virgilio AL; León IE
    Metallomics; 2019 Mar; 11(3):666-675. PubMed ID: 30839008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maltol-derived ruthenium-cymene complexes with tumor inhibiting properties: the impact of ligand-metal bond stability on anticancer activity in vitro.
    Kandioller W; Hartinger CG; Nazarov AA; Bartel C; Skocic M; Jakupec MA; Arion VB; Keppler BK
    Chemistry; 2009 Nov; 15(45):12283-91. PubMed ID: 19821465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-based neutral ruthenium(II) arene complex: selective anticancer action.
    Wu CH; Wu DH; Liu X; Guoyiqibayi G; Guo DD; Lv G; Wang XM; Yan H; Jiang H; Lu ZH
    Inorg Chem; 2009 Mar; 48(6):2352-4. PubMed ID: 19220049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel ruthenium(II) arene based intercalator with potent anticancer activity.
    Ruiz J; Vicente C; de Haro C; Bautista D
    Dalton Trans; 2009 Jul; (26):5071-3. PubMed ID: 19562164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arene ruthenium complexes as anticancer agents.
    Süss-Fink G
    Dalton Trans; 2010 Feb; 39(7):1673-88. PubMed ID: 20449402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of Ru-arene Complexes for Antitumor Drugs.
    Su W; Li Y; Li P
    Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plectin promotes tumor formation by B16 mouse melanoma cells via regulation of Rous sarcoma oncogene activity.
    Mizuta K; Matsubara T; Goto A; Addison WN; Nakatomi M; Matsuo K; Tada-Shigeyama Y; Yaginuma T; Honda H; Yoshioka I; Kokabu S
    BMC Cancer; 2022 Aug; 22(1):936. PubMed ID: 36038818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo.
    Stíbal D; Therrien B; Süss-Fink G; Nowak-Sliwinska P; Dyson PJ; Čermáková E; Řezáčová M; Tomšík P
    J Biol Inorg Chem; 2016 Jul; 21(4):443-52. PubMed ID: 27040952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organometallic ruthenium inhibitors of glutathione-S-transferase P1-1 as anticancer drugs.
    Ang WH; De Luca A; Chapuis-Bernasconi C; Juillerat-Jeanneret L; Lo Bello M; Dyson PJ
    ChemMedChem; 2007 Dec; 2(12):1799-806. PubMed ID: 17918761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing the bioavailability of Ru(III) anticancer complexes through hydrophobic albumin interactions.
    Webb MI; Wu B; Jang T; Chard RA; Wong EW; Wong MQ; Yapp DT; Walsby CJ
    Chemistry; 2013 Dec; 19(50):17031-42. PubMed ID: 24203647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of Organometallic Ruthenium Anticancer Complexes to DNA: Thermodynamic Base and Sequence Selectivity.
    Liu S; Liang A; Wu K; Zeng W; Luo Q; Wang F
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30041439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: passing the nanomolar barrier.
    Fetzer L; Boff B; Ali M; Xiangjun M; Collin JP; Sirlin C; Gaiddon C; Pfeffer M
    Dalton Trans; 2011 Sep; 40(35):8869-78. PubMed ID: 21837342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organometallic ruthenium anticancer complexes inhibit human glutathione-S-transferase π.
    Lin Y; Huang Y; Zheng W; Wang F; Habtemariam A; Luo Q; Li X; Wu K; Sadler PJ; Xiong S
    J Inorg Biochem; 2013 Nov; 128():77-84. PubMed ID: 23942162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity.
    Banerjee S; Chakravarty AR
    Acc Chem Res; 2015 Jul; 48(7):2075-83. PubMed ID: 26158541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds.
    Guichard SM; Else R; Reid E; Zeitlin B; Aird R; Muir M; Dodds M; Fiebig H; Sadler PJ; Jodrell DI
    Biochem Pharmacol; 2006 Feb; 71(4):408-15. PubMed ID: 16360645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.
    Peacock AF; Sadler PJ
    Chem Asian J; 2008 Nov; 3(11):1890-9. PubMed ID: 18712745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.